Literature DB >> 32222796

Control of postpartum hemorrhage in women with placenta accreta spectrum using prophylactic balloon occlusion combined with Pituitrin intra-arterial infusion.

Mengjun Dai1, Guangxin Jin1, Jianhua Lin2, Yu Zhang2, Yunyan Chen2, Qiong Zhou2, Xuebin Zhang3.   

Abstract

OBJECTIVES: The aim of this study is to evaluate the efficacy of prophylactic internal iliac artery balloon occlusion combined with Pituitrin intra-arterial infusion in the control of postpartum hemorrhage in women with placenta accreta spectrum (PAS).
METHODS: This is a prospective and non-randomized controlled study. The participants were assigned into three groups: without balloon catheterization (non-BC) group, balloon catheterization (BC) group, and Pituitrin combined with balloon catheterization (PBC) group. The primary outcomes were estimated blood loss (EBL) and the units of transfused packed red blood cells (PRBC). The secondary outcome was the incidence of hysterectomy.
RESULTS: A total of 100 participants were recruited between August 2013 and November 2018 and assigned into the respective groups as follows: 27 in the non-BC group, 22 in the BC group, and 51 in the PBC group. No statistical differences were found in demographic characteristics among the three groups. There was a trend of lower EBL, PRBC, and hysterectomy rate in the BC group than those in the non-BC group, while all values showed no significant differences (all p > 0.05). Patients in the PBC group had significantly lower EBL, PRBC, and hysterectomy rate compared with those in the non-BC group (all p < 0.05). Linear regression analysis revealed that the PBC (vs. others) was negatively correlated with EBL and the non-BC (vs. others) independently predicted more EBL.
CONCLUSIONS: Balloon occlusion combined with Pituitrin infusion is an effective treatment method which significantly reduced EBL, PRBC, and hysterectomy rate in patients with PAS. KEY POINTS: • Internal iliac artery balloon occlusion combined with Pituitrin intra-arterial infusion can significantly decrease EBL, PRBC, and hysterectomy rate during cesarean section in patients with PAS. • Cesarean section without balloon occlusion and placenta accreta depth are two independent risk factors for EBL in patients with PAS.

Entities:  

Keywords:  Pituitrin intra-arterial infusion; Placenta accreta spectrum; Postpartum hemorrhage; Prophylactic internal iliac artery balloon occlusion

Mesh:

Substances:

Year:  2020        PMID: 32222796     DOI: 10.1007/s00330-020-06813-w

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

1.  Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Authors:  Xingshun Qi; Zhaohui Bai; Qiang Zhu; Gang Cheng; Yu Chen; Xiaowei Dang; Huiguo Ding; Juqiang Han; Lei Han; Yingli He; Fanpu Ji; Hongxu Jin; Bimin Li; Hongyu Li; Yiling Li; Zhiwei Li; Bang Liu; Fuquan Liu; Lei Liu; Su Lin; Dapeng Ma; Fanping Meng; Ruizhao Qi; Tianshu Ren; Lichun Shao; Shanhong Tang; Yufu Tang; Yue Teng; Chunhui Wang; Ran Wang; Yunhai Wu; Xiangbo Xu; Ling Yang; Jinqiu Yuan; Shanshan Yuan; Yida Yang; Qingchun Zhao; Wei Zhang; Yongping Yang; Xiaozhong Guo; Weifen Xie
Journal:  Therap Adv Gastroenterol       Date:  2022-05-18       Impact factor: 4.802

2.  The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.

Authors:  Anisodowleh Nankali; Nader Salari; Mohsen Kazeminia; Masoud Mohammadi; Samira Rasoulinya; Melika Hosseinian-Far
Journal:  Reprod Biol Endocrinol       Date:  2021-03-04       Impact factor: 5.211

3.  Image Analysis Application of Motherwort Total Alkaloid Injection in the Treatment of Postabortion Hemorrhage.

Authors:  Wenjing Wang
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

4.  Innovations in the prevention and treatment of postpartum hemorrhage: Analysis of a novel medicines development pipeline database.

Authors:  Annie R A McDougall; Maya Goldstein; Andrew Tuttle; Anne Ammerdorffer; Sara Rushwan; Roxanne Hastie; A Metin Gülmezoglu; Joshua P Vogel
Journal:  Int J Gynaecol Obstet       Date:  2022-06       Impact factor: 4.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.